• CAPLACIZUMAB chembl:CHEMBL2109624 Approved

    Alternate Names:

    CAPLACIZUMAB-YHDP
    ALX-0081
    CABLIVI
    CAPLACIZUMAB

    Drug Info:

    FDA Approval not approved
    Drug Class antibody fragment
    Drug Indications antithrombotic
    (0 More Sources)

    Publications:

  • Interaction Score: 13.25

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction von Willebrand factor inhibitor
    Direct Interaction yes
    Trial Name ALX-0081, ALX-0681, anti-von Willebrand factor nanobodies

    PMIDs:
    None found